Loading
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (2 ops.)
Latest filing published 09 Feb 2026 for Generation Bio Co.. Read the official filing
Filing timeline
BuySaleCharles A. Rowland Jr.
Insider track record
Disclosed buys
4
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Charles A. Rowland Jr.: trading record in brief
This profile gathers the share dealings of Charles A. Rowland Jr. across 5 companies, led by Generation Bio Co., Nabriva Therapeutics plc and Viking Therapeutics, Inc. We count 13 filings; the first trade dates from 2 June 2021 and the latest from 9 February 2026.
In open-market terms, that means 4 purchases worth €505k on one side and 2 sales worth €2,234 on the other. Netting one side against the other leaves €503k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 4 share grants and 1 option exercise.
In size, the median ticket on the buying side is €95k. Of 4 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 9 February 2026 with a transaction in Generation Bio Co. The last insider purchase was made public on 5 December 2023, 1,048 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Charles A. Rowland Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
53,475 sharesCommon StockSEC:0001104659-26-012196:0
3,150 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-26-003110:0
16,000 shares@ US$4.4860.8% of flowCommon Stock, par value $0.00001 per shareSEC:0001193125-25-254300:0
12,294 sharesOrdinary SharesSEC:0000950170-24-007074:0
192,960 shares@ US$1.3145.9% of flowCommon StockSEC:0001415889-23-015864:0
Canonical exit: 29 Feb 2024 (T+90)
40,000 shares@ US$1.08100.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-030796:0
15,750 shares@ US$5.2616.3% of flowCommon StockSEC:0001415889-22-009796:0
Canonical exit: 18 Dec 2022 (T+90)
17,147 shares@ US$5.4118.4% of flowCommon StockSEC:0001415889-22-009776:0
Canonical exit: 14 Dec 2022 (T+90)
18,784 shares@ US$5.20419.4% of flowCommon StockSEC:0001415889-22-009671:0
Canonical exit: 12 Dec 2022 (T+90)
8,496 shares@ US$0.17548.0% of flowOrdinary SharesSEC:0001104659-22-085790:0
777 shares@ US$1.2035.1% of flowOrdinary SharesSEC:0001104659-21-100288:0
17,500 shares0Ordinary SharesSEC:0001104659-21-098427:0
2,250 shares0Common StockSEC:0001179110-21-006417:0
13 of 13 declarations
